fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Dry-eye disorder improved by modulating hormone levels

Written by | 13 Mar 2022

Health issues for people over sixty commonly involve the heart and other vital organs. So do eye-related conditions such as cataracts and glaucoma, but dry eyes don’t often… read more.

Eating disorders linked to diabetic eye issues

Written by | 27 Feb 2022

Eating disorders are associated with an increased risk of people with diabetes developing diabetic retinopathy — a condition that can cause blindness if untreated — according to new… read more.

Cause, develop pharmacological treatment for reducing retinitis pigmentosa vision loss

Written by | 28 Jan 2022

Inhibiting ceramide accumulation in retina protects photoreceptors, improves vision. Researchers from the University of California, Irvine have discovered that the absence of Adiponectin receptor 1 protein (AdipoR1), one… read more.

New real-world data show high rate of patient adherence to Tepezza for thyroid eye disease (TED) – Horizon Therapeutics

Written by | 14 Jan 2022

Horizon Therapeutics plc announced findings of a real-world adherence analysis of Tepezza for the treatment of TED ( Thyroid Eye Disease) at the American Academy of Ophthalmology Annual… read more.

Molecular link traced from gene to late-onset retinal degeneration

Written by | 19 Dec 2021

Clinical trial planning underway to test the widely used diabetes drug metformin as a preventive treatment for the blinding eye disease. Scientists have discovered that gene therapy and… read more.

Stem cell therapy as potential glaucoma treatment

Written by | 2 Dec 2021

Oregon Health & Science University is part of a national research project investigating stem cell therapy as a potential treatment for glaucoma, the world’s second leading cause of blindness…. read more.

FDA approves Vuity for presbyopia – Allergan / AbbVie

Written by | 2 Nov 2021

Allergan announced the FDA approval of Vuity (pilocarpine HCl ophthalmic solution) 1.25% for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. Vuity is… read more.

Eye conditions linked to heightened risk of dementia

Written by | 20 Sep 2021

Risk of dementia increases with age-related macular degeneration, cataract and diabetes-related eye disease, but not glaucoma. Age-related macular degeneration, cataract and diabetes-related eye disease are linked to an… read more.

Horizon Therapeutics initiates randomized controlled clinical trial evaluating Tepezza for the treatment of chronic (inactive) thyroid eye disease

Written by | 14 Sep 2021

Horizon Therapeutics plc has announced that the first patient has been enrolled in a Phase IV clinical trial evaluating the efficacy and safety of Tepezza for the treatment… read more.

Heart disease is in the eye of the beholder

Written by | 4 Jul 2021

In the paper published in EClinical Medicine by The Lancet, the research team examined lesions of the retina, the inner-most, light-sensitive layer of the eye, to determine if a cardiovascular… read more.

No glaucoma risk with hormonal contraceptives

Written by | 3 Jul 2021

Women who currently use hormonal contraceptives face more than a 2-fold higher risk of developing glaucoma, according to an analysis of electronic medical records for women aged 15-45… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.